APELLIS UK LIMITED

Active London

Wholesale of pharmaceutical goods

11 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
A

APELLIS UK LIMITED

Wholesale of pharmaceutical goods

Founded 20 Mar 2020 Active London, United Kingdom 11 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
Accounts Submitted 27 Nov 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 29 Apr 2026 Next due 2 Apr 2027 11 months remaining
Net assets £564K £185K 2024 year on year
Total assets £2M £654K 2024 year on year
Total Liabilities £1M £839K 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

6th Floor 2 Kingdom Street Paddington London W2 6BD United Kingdom

Website

www.example.com

Full company profile for APELLIS UK LIMITED (12528378), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 20 Mar 2020. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2020–2024)

Cash in Bank

£637.10k

Increased by £318.82k (+100%)

Net Assets

£563.52k

Increased by £184.86k (+49%)

Total Liabilities

£1.08M

Decreased by £839.29k (-44%)

Turnover

£6.42M

Employees

11

Increased by 1 (+10%)

Debt Ratio

66%

Decreased by 18 (-21%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 3 Shares £150k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
7 Dec 20211£50k£50k
9 Nov 20211£50k£50k
12 Jul 20211£50k£50k

Officers

Officers

2 active 1 resigned
Status
Hay, Andrew Robert HamiltonDirectorBritishSwitzerland5828 Feb 2025Active
Hillmen, Peter, ProfDirectorBritishUnited Kingdom6428 Feb 2025Active

Shareholders

Shareholders (1)

Apellis International Gmbh
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Apellis Pharmaceuticals, Inc.

United States Of America

Active
Notified 20 Mar 2020
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

APELLIS UK LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
29 Apr 2026Confirmation StatementConfirmation statement made on 19 Mar 2026 with no updates
27 Nov 2025AccountsAnnual accounts made up to 31 Dec 2024
31 Mar 2025AddressChange Sail Address Company With Old Address New Address
28 Mar 2025Confirmation StatementConfirmation statement made on 19 Mar 2025 with no updates
4 Mar 2025OfficersAppointment of Andrew Robert Hamilton Hay as director on 28 Feb 2025
29 Apr 2026 Confirmation Statement

Confirmation statement made on 19 Mar 2026 with no updates

27 Nov 2025 Accounts

Annual accounts made up to 31 Dec 2024

31 Mar 2025 Address

Change Sail Address Company With Old Address New Address

28 Mar 2025 Confirmation Statement

Confirmation statement made on 19 Mar 2025 with no updates

4 Mar 2025 Officers

Appointment of Andrew Robert Hamilton Hay as director on 28 Feb 2025

Recent Activity

Latest Activity

Confirmation statement made on 19 Mar 2026 with no updates

2 days ago on 29 Apr 2026

Annual accounts made up to 31 Dec 2024

5 months ago on 27 Nov 2025

Change Sail Address Company With Old Address New Address

1 years ago on 31 Mar 2025

Confirmation statement made on 19 Mar 2025 with no updates

1 years ago on 28 Mar 2025

Appointment of Andrew Robert Hamilton Hay as director on 28 Feb 2025

1 years ago on 4 Mar 2025